Hypertriglyceridemia as a Result of Human apo CII Gene Expression in Transgenic Mice
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Primary and secondary hypertriglyceridemia is common in the general population, but the biochemical basis for this disease is largely unknown. With the use of transgenic technology, two lines of mice were created that express the human apolipoprotein CIII gene. One of these mouse lines with 100 copies of the gene was found to express large amounts of the protein and to be severely hypertriglyceridemic. The other mouse line with one to two copies of the gene expressed low amounts of the protein, but nevertheless manifested mild hypertriglyceridemia. Thus, overexpression of apolipoprotein CIII can be a primary cause of hypertriglyceridemia in vivo and may provide one possible etiology for this common disorder in humans.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“High ApoC-III levels were shown to increase total triglyceride levels by an accumulation of VLDL and chylomicrons [166–169]”
From Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention (2023) · cites this paper as [167]
In the citing paper
“These data are consistent with previous studies showing that transgenic mice with overexpression of human apolipoprotein C3 had hypertriglyceridemia due to decreased lipoprotein lipase activity,16”
From Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease (2010) · cites this paper as [16]
Citations
Cites
The Metabolic Basis of Inherited Disease.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-503_7 · Cited by 7,786
NF-κB: A pleiotropic mediator of inducible and tissue-specific gene control
Lenardo, M. J., & Baltimore, D. (1989) · Cell · doi:10.1016/0092-8674(89)90833-7 · Cited by 1,585
Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein
Virgil Brown, W., & Baginsky, M. L. (1972) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(72)80149-9 · Cited by 491
Ginsberg, H. N., Le, N. A., Goldberg, I. J., Gibson, J. C., Rubinstein, A., Wang-Iverson, P., Norum, R., & Brown, W. V. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112713 · Cited by 424
Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III.
Wang, C. S., McConathy, W. J., Kloer, H. U., & Alaupovic, P. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111711 · Cited by 414
Karathanasis, S. K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.19.6374 · Cited by 358
PLASMA TRIGLYCERIDE AS A RISK FACTOR FOR CORONARY HEART DISEASE
AUSTIN, M. A. (1989) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115130 · Cited by 352
Familial Deficiency of Apolipoproteins A-I and C-III and Precocious Coronary-Artery Disease
Norum, R. A., Lakier, J. B., Goldstein, S., Angel, A., Goldberg, R. B., Block, W. D., Noffze, D. K., Dolphin, P. J., Edelglass, J., Bogorad, D. D., et al. (1982) · New England Journal of Medicine · doi:10.1056/nejm198206243062503 · Cited by 304
Weintraub, M. S., Eisenberg, S., & Breslow, J. L. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112926 · Cited by 261
Self-citationWalsh, A., Ito, Y., & Breslow, J. L. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83374-9 · Cited by 241
Self-citationApolipoprotein C-II and C-III levels in hyperlipoproteinemia
Schonfeld, G., George, P. K., Miller, J., Reilly, P., & Witztum, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90004-0 · Cited by 176
Further Observations on the Activation and Inhibition of Lipoprotein Lipase by Apolipoproteins
KRAUSS, R. M., HERBERT, P. N., LEVY, R. I., & FREDRICKSON, D. S. (1973) · Circulation Research · doi:10.1161/01.res.33.4.403 · Cited by 174
Linkage of human apolipoproteins A-I and C-III genes
Karathanasis, S. K., McPherson, J., Zannis, V. I., & Breslow, J. L. (1983) · Nature · doi:10.1038/304371a0 · Cited by 169
Self-citationRees, A., Stocks, J., Sharpe, C. R., Vella, M. A., Shoulders, C. C., Katz, J., Jowett, N. I., Baralle, F. E., & Galton, D. J. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112062 · Cited by 158
Carlson, L. A., & Ballantyne, D. (1976) · Atherosclerosis · doi:10.1016/0021-9150(76)90016-2 · Cited by 139
Langlois, S., Deeb, S., Brunzell, J. D., Kastelein, J. J. P., & Hayden, M. R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.3.948 · Cited by 112
Lipid metabolism and atherosclerosis
Assmann, G. (1982) · Schattauer eBooks · Cited by 112
Human apolipoprotein A-I--C-III gene complex is located on chromosome 11.
Bruns, G. A. P., Karathanasis, S. K., & Breslow, J. L. (1984) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.4.2.97 · Cited by 110
Self-citationReue, K., Leff, T., & Breslow, J. L. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68723-x · Cited by 104
Self-citationMalmendier, C. L., Lontie, J., Delcroix, C., Dubois, D. Y., Magot, T., & Roy, L. D. (1989) · Atherosclerosis · doi:10.1016/0021-9150(89)90075-0 · Cited by 94
Kashyap, M. L., Srivastava, L., Hynd, B. A., Gartside, P. S., & Perisutti, G. (1981) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37352-1 · Cited by 84
Partial gene duplication involving exon-Alu interchange results in lipoprotein lipase deficiency.
Devlin, R. H., Deeb, S. S., Brunzell, J. D., & Hayden, M. R. (1990) · PubMed · Cited by 83
Isolation and characterization of cDNA clones corresponding to two different human apoC-III alleles.
Karathanasis, S. K., Zannis, V. I., & Breslow, J. L. (1985) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34359-5 · Cited by 73
Self-citationAalto‐Setälä, K., KONTULA, K. K., Sane, T., Nieminen, M. S., & Nikkilä, E. A. (1987) · Atherosclerosis · doi:10.1016/0021-9150(87)90190-0 · Cited by 72
Schonfeld, G., & Pfleger, B. A. (1971) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39481-5 · Cited by 67
Taş, S. (1989) · Clinical Chemistry · doi:10.1093/clinchem/35.2.256 · Cited by 63
Sane, T., & Nikkilä, E. A. (1988) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.8.3.217 · Cited by 60
Fojo, S. S., Lohse, P., Parrott, C. L., Baggio, G., Gabelli, C., THOMAS, F. J., Hoffman, J., & Brewer, H. B. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114287 · Cited by 56
Ito, Y., Breslow, J. L., & Chait, B. T. (1989) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38224-9 · Cited by 45
Self-citationCatapano, A. L. (1980) · Atherosclerosis · doi:10.1016/0021-9150(80)90182-3 · Cited by 40
The Status of Hypertriglyceridemia as a Risk Factor for Coronary Heart Disease
Avins, A. L., Haber, R. J., & Hulley, S. B. (1989) · Clinics in Laboratory Medicine · doi:10.1016/s0272-2712(18)30647-4 · Cited by 24
Dunn, F. L., Grundy, S. M., Bilheimer, D. W., Havel, R. J., & Raskin, P. (1985) · Metabolism · doi:10.1016/0026-0495(85)90220-3 · Cited by 22
Research works printed but not linked: 2
- COLE, T.G., BIOCOMMUNIQUE 4: 4 (1988).
- PROTTER, A. A., DNA-A JOURNAL OF MOLECULAR & CELLULAR BIOLOGY 3: 449 (1984).
Cited by
Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism*
Desvergne, B., & Wahli, W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.5.0380 · Cited by 3,086
Role of LXRs in control of lipogenesis
Schultz, J. R., Tu, H., Luk, A., Repa, J. J., Medina, J. C., Li, L., Schwendner, S., Wang, S., Thoolen, M., Mangelsdorf, D. J., et al. (2000) · Genes & Development · doi:10.1101/gad.850400 · Cited by 1,499
Schoonjans, K., Staels, B., & Auwerx, J. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42003-6 · Cited by 1,216
Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state
Patsch, J. R., Miesenböck, G., Hopferwieser, T., Mühlberger, V, Knapp, E., Dunn, J. K., Gotto, A. M., & Patsch, W. (1992) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.12.11.1336 · Cited by 1,122
Schoonjans, K., Staels, B., & Auwerx, J. (1996) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(96)00066-5 · Cited by 1,047
Metadata
- Authors
- Ito, Y., Azrolan, N., O'Connell, A., Walsh, A., & Breslow, J. L.
- Affiliations
- Rockefeller University (US)
- Venue
- Science
- Published
- 1990-08-17
- Volume
- 249
- Issue
- 4970
- Pages
- 790-793
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1963872182
- Semantic Scholar
- be3dbcf0ed6239b54ab96520181db05f1ba0399f
- Cited by
- 539
- References
- 32
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 7 · 2023: 9 · 2022: 7 · 2021: 10 · 2020: 9 · 2019: 16 · 2018: 10 · 2017: 17 · 2016: 13 · 2015: 15 · 2014: 16 · 2013: 18 · 2012: 7
- FWCI
- 21.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01hl033714-17, 5r37hl036461-09)
- National Heart, Lung, and Blood Institute (HL 33714, HL-36461, HL-33435)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- hypertriglyceridemia, apolipoprotein C-III, transgenic mice, gene overexpression, primary hypertriglyceridemia, secondary hypertriglyceridemia, triglyceride metabolism, gene dosage
- MeSH terms
- Animals, Apolipoproteins C, Chylomicrons, Cloning, Molecular, DNA Restriction Enzymes, DNA, Recombinant, Humans, Lipoproteins, VLDL, Mice, Inbred CBA, Mice, Inbred C57BL, Mice, Transgenic, Nucleic Acid Hybridization, RNA, Messenger, Triglycerides, Hypertriglyceridemia, Gene Expression, Mice, Apolipoprotein C-III
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.